[
  {
    "date": "2023-06-30",
    "symbol": "IXHL",
    "period": "FY",
    "otherincome": 1376645,
    "otheroperatingincomeexpense": 1376645,
    "administrativeexpense": 568954,
    "advertisingexpense": 1852416,
    "researchanddevelopmentexpense": 9364796,
    "compliancelegalandregulatory": 2632069,
    "adjustmentsforsharebasedpayments": 3191640,
    "occupancyexpense": 124628,
    "depreciationexpense": 130946,
    "employeebenefitsexpense": 3490754,
    "operatingexpense": 21356203,
    "profitlossbeforetax": -19979558,
    "profitlossfromcontinuingoperations": -19979558,
    "comprehensiveincome": -19979558,
    "basicearningslosspershare": -1.3,
    "dilutedearningslosspershare": -1.3,
    "cashandcashequivalents": 33363228,
    "tradeandothercurrentreceivables": 287478,
    "othercurrentassets": 1035181,
    "currentassets": 34685887,
    "propertyplantandequipment": 443652,
    "rightofuseassets": 743734,
    "intangibleassetsotherthangoodwill": 52717427,
    "noncurrentassets": 53904813,
    "assets": 88590700,
    "tradeandothercurrentpayables": 3675090,
    "currentleaseliabilities": 170656,
    "currentliabilities": 3845746,
    "noncurrentleaseliabilities": 616087,
    "noncurrentliabilities": 616087,
    "liabilities": 4461833,
    "netassetsliabilities": 84128867,
    "issuedcapital": 150842248,
    "capitalreserve": 12061087,
    "retainedearnings": -78774468,
    "equity": 84128867,
    "increasedecreasethroughexerciseofoptions": 2027,
    "increasedecreasethroughoptionsissuedtoadvisors": 684000,
    "increasedecreasethroughoptionplacements": 108257,
    "increasedecreasethroughassetacquisitionsharesissued": 49088139,
    "increasedecreasethroughsharebasedpaymenttransactions": 3191640,
    "increasedecreasethroughshareplacements": 13000000,
    "increasedecreasethroughsharesissuedtoadvisors": 2945288,
    "shareissuerelatedcost": 780000,
    "profitloss": -19979558,
    "othercashreceiptsfromoperatingactivities": 1013879,
    "paymentstosuppliersforgoodsandservicesandtoandonbehalfofemployees": 17285861,
    "interestpaidclassifiedasoperatingactivities": 329157,
    "cashflowsfromusedinoperatingactivities": -15942825,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 476873,
    "cashflowsfromusedininvestingactivities": -476873,
    "proceedsfromissuingshares": 12330284,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 54717,
    "cashflowsfromusedinfinancingactivities": 12275567,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": -4144131,
    "effectofexchangeratechangesoncashandcashequivalents": 6428,
    "descriptionofaccountingpolicyfornatureofoperationspolicytextblock": "Nature of Operations",
    "descriptionofaccountingpolicyforneworamendedaccountingstandardsandinterpretationsadoptedpolicytextblock": "New or amended Accounting Standards and Interpretationsadopted",
    "descriptionofaccountingpolicyforstatementofcompliancepolicytextblock": "Statement of compliance",
    "descriptionofaccountingpolicyforparententityinformationpolicytextblock": "<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify\"><b>Parent entity information</b></p><p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify\">In accordance with AASB 10 (IFRS 10) <i>ConsolidatedFinancial Statements</i>, these consolidated financial statements present the results of the Group only. Supplementary information aboutthe parent entity is disclosed in note 24.</p>",
    "descriptionofaccountingpolicyforprinciplesofconsolidationpolicytextblock": "Principles of consolidation",
    "descriptionofaccountingpolicyforoperatingsegmentspolicytextblock": "Operating segments",
    "descriptionofaccountingpolicyforforeigncurrencytransactionspolicytextblock": "Foreign currency transactions",
    "descriptionofaccountingpolicyforcurrentandnoncurrentclassificationpolicytextblock": "Current and non-current classification",
    "descriptionofaccountingpolicyforcashpolicytextblock": "<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify\"><b>Cash</b></p><p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify\">Cash and deposits held at call with financialinstitutions, other short-term, highly liquid investments with original maturities of three months or less that are readily convertibleto known amounts of cash and which are subject to an insignificant risk of changes in value.</p>",
    "descriptionofaccountingpolicyforrightofuseleasedassetspolicytextblock": "Right-of-use leased assets",
    "descriptionofaccountingpolicyfordividendspolicytextblock": "<p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify\"><b>Dividends</b></p><p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify\">Dividends are recognized when declared duringthe financial years.</p>",
    "descriptionofaccountingpolicyforgoodsandservicestaxgstandothersimilartaxespolicytextblock": "Goods and Services Tax (‘GST’)and other similar taxes",
    "descriptionofaccountingpolicyforadoptionofnewandrevisedstandardspolicytextblock": "Adoption of new and revised standards",
    "descriptionofaccountingpolicyfornewaccountingstandardsnotyetadoptedpolicytextblock": "Accounting standards and interpretations issuedbut not yet effective",
    "scheduleofotherincometabletextblock": "Consolidated             2023      2022       Other income (point in time)     $      $       Interest      362,766       6,271       Refundable R&D tax offset      1,013,879       782,383              1,376,645       788,654",
    "scheduleofincometaxexpensebenefittabletextblock": "The prima facie income tax benefit on pre-taxaccounting loss from operations reconciles to the income tax benefit in the financial statements as follows:",
    "scheduleoftradeandotherreceivablescurrenttabletextblock": "Current     Consolidated             2023      2022             $      $                            GST recoverable      287,478       294,717              287,478       294,717",
    "scheduleofotherassetscurrenttabletextblock": "Prepayments1      935,172       59,836       Office rental bond      100,009       24,124              1,035,181       83,960",
    "scheduleofkeyassumptionswereusedintherelieffromroyaltymodeltabletextblock": "The following key assumptions were used in the Relief from Royaltymodel:",
    "scheduleofleaseliabilitiestabletextblock": "Current      170,656       -       Non-current      616,087       -              786,743       -",
    "scheduleoftradeandotherpayablescurrenttabletextblock": "Consolidated             2023      2022             $      $                            Trade payables      2,707,441       1,300,696       Accrued expenses      641,031       415,449       Employee leave entitlements      326,618       294,388              3,675,090       2,010,533",
    "disclosureofissuedofsharecapitaltabletextblock": "Consolidated             2023      2022             $      $             150,842,248       86,586,794",
    "disclosureofreserveswithinequitytabletextblock": "Equity based premium reserve     Consolidated             2023      2022             $      $       Balance at 1 July 2022      8,077,191       6,612,641       Options issued to advisors1      684,000       -       Issues of new options – placement2      108,257       -       Equity instruments issued to management and directors3      3,191,640       1,464,550       At 30 June 2023      12,061,087       8,077,191",
    "disclosureofshareoptionstabletextblock": "The following share options were issued to employeesand consultants as share based payments during the year ended 30 June 2023:",
    "disclosureofremunerationofauditorstextblock": "Consolidated      Consolidated             2023      2022             $      $       Audit or review of the financial reports of the company                    Amounts received & receivable by the auditor:                    Audit services – PKF Brisbane Audit      97,750       85,000       Audit services – HLB Mann Judd      -       23,138       Audit services – Withum Smith & Brown (US auditor)      -       357,208              97,750       465,346",
    "revenuefrominterest": 362766,
    "otherrevenue": 1013879,
    "otherexpense": 1092033,
    "taxexpenseincomeatapplicabletaxrate": 4994890,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 1259881,
    "nonassessableincome": 253439,
    "deferredtaxassets": 3988448,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 29636125,
    "taxbenefitarisingfrompreviouslyunrecognisedtaxlosstaxcreditortemporarydifferenceofpriorperiodusedtoreducedeferredtaxexpense": 7409031,
    "applicabletaxrate": 0.25,
    "taxbenefitrate": 0.25,
    "weightedaverageshares": 1536826010,
    "cashonhand": 33363228,
    "cash": 33363228,
    "adjustmentsforsharebasedpayment": 3191640,
    "releaseofgamedayreserveofsalesrefund": 130946,
    "adjustmentsforincreasedecreaseinotheroperatingpayables": -6428,
    "adjustmentsfordecreaseincreaseintradeandotherreceivable": 7240,
    "adjustmentsfordecreaseincreaseinothercurrentassets": -951221,
    "adjustmentsforincreasedecreaseintradeandotherpayable": 1561321,
    "adjustmentsforincreasedecreaseinothercurrentliabilities": 103235,
    "cashflowsfromusedinoperatingactivitiescontinuingoperations": -15942825,
    "prepayments": 935172,
    "receivablesfromrentalofproperties": 100009,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 476873,
    "depreciationpropertyplantandequipment": 33221,
    "impairmentlossrecognisedinprofitorlossintangibleassetsandgoodwill": 33221,
    "acquisitionsthroughbusinesscombinationsintangibleassetsandgoodwill": 22822000,
    "intangibleassetfairvalueusedasdeemedcost": 22822000,
    "royaltyrate": 0.0525,
    "terminalgrowthrate": 0.112,
    "posttaxdiscountrate": 0.425,
    "discountratepremium": 0.01,
    "taxrate": 0.3,
    "compoundannualrevenuegrowthrate": 0.1018,
    "additionstorightofuseassets": 841460,
    "depreciationrightofuseassets": 97726,
    "leaseliabilities": 786743,
    "financeincomecost": 33609,
    "comprehensiveincomeattributabletoownersofparent": 131335,
    "tradeandotherpayablestotradesuppliers": 2707441,
    "currentaccruedexpensesandothercurrentliabilities": 641031,
    "currentprovisionsforemployeebenefits": 326618,
    "numberofsharesissuedandfullypaid": 150842248,
    "issuedcapitalordinaryshares": 150842248,
    "issuesofnewsharesplacements": 13000000,
    "numberofsharesissuesofnewsharesplacements": 63414635,
    "issuesofnewsharesacquistion": 49088139,
    "numberofsharesissuesofnewsharesacquistion": 218169506,
    "exerciseofoptions": 2027,
    "sharesinlieuofadvisorfeesinshares": 2945288,
    "numberofsharessharesinlieuofadvisorfees": 13090170,
    "optionsissuedtoadvisor": 684000,
    "numberofoptionsgrantedtodirectors": 2500000,
    "shareoptionsgrantedtodirectorsgrantdate": "2022-11-29",
    "expirydateofoptionsgrantedtodirectors": "2024-05-31",
    "exercisepriceofoptionsgrantedtodirectors": 1,
    "totalfairvalueofoptionsgrantedtodirectors": 57500,
    "numberofoptionsgrantedtothirdparties": 3000000,
    "shareoptiongrantedtothirdpartiesgrantdate": "2022-08-04",
    "expirydateofoptionsgrantedtothirdparties": "2025-08-04",
    "exercisepriceofoptionsgrantedtothirdparties": 0.61,
    "totalfairvalueoptionsgrantedtothirdparties": 243000,
    "shareoptions": 14000000,
    "totaloptions": 771500,
    "adjustedweightedaverageshares": 2500000,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.9,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0318,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P1Y6M",
    "exercisepriceshareoptionsgranted2019": 100,
    "weightedaveragesharepriceshareoptionsgranted2019": 23.5,
    "vestingdateperiod": "29-Nov-22",
    "auditorsremunerationforauditservices": 97750,
    "auditorsremuneration": 97750,
    "accruals": 3298131,
    "contractliabilities": 3298131,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 2296996,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 66757,
    "keymanagementpersonnelcompensationsharebasedpayment": 2715156,
    "keymanagementpersonnelcompensation": 5078909,
    "financialassets": 32717079,
    "equityandliabilities": 32717079,
    "averageeffectivetaxrate": 0.3,
    "impairmentlossrecognisedinothercomprehensiveincome": 19980000,
    "netcashoutflowsfromoperations": 15940000,
    "heldtotalcash": 33360000,
    "propertyplantandequipmentusefullives": "P25Y",
    "finitelivedintangibleassetusefullifes": "P13Y",
    "numberofoperatingsegment": 3,
    "numberofgeographicalsegment": 1,
    "percentageoftotalrevenuefrommedicinalcannabis": 1,
    "usefullifemeasuredasperiodoftimebiologicalassetsatcost": "P13Y",
    "descriptionofgrowthrateusedtoextrapolatecashflowprojections": 0.112,
    "sharesreservedforissueunderoptionsandcontractsforsaleofshare": 9000000,
    "numberofoutstandingshareoptions": 105800651,
    "planassetsatfairvalue": 1866328,
    "unrecognizedcompensationcost": 895318,
    "exercisepriceofoutstandingshareoptions2019": 0.35,
    "recognizedcompensationcost": 1325311,
    "weightedaverageperiodterm": "P1Y4M20D",
    "ordinaryshareissued": 218169506,
    "feeandcommissionincome": 247122,
    "otherfeeandcommissionincome": 254000,
    "proportionofownershipinterestinsubsidiary": 1,
    "entityregistrantname": "Incannex Healthcare Limited",
    "tradingsymbol": "IXHL",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "--06-30",
    "entitycommonstocksharesoutstanding": 1587010366,
    "amendmentflag": "false",
    "entitycentralindexkey": 1873875,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2023-06-30",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "false",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-41106",
    "entityincorporationstatecountrycode": "C3",
    "entityaddressaddressline1": "Suite 105",
    "entityaddressaddressline2": "8 Century CircuitNorwest",
    "entityaddresspostalzipcode": 2153,
    "entityaddresscityortown": "NSW",
    "entityaddresscountry": "AU",
    "contactpersonnelname": "Joel Latham",
    "cityareacode": 61,
    "localphonenumber": "425 703 805",
    "contactpersonnelemailaddress": "joel@incannex.com.au",
    "security12btitle": "Ordinary Shares, as represented by American Depositary Shares",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "documentfinstmterrorcorrectionflag": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "auditorfirmid": 6622,
    "auditorname": "PKF BRISBANE AUDIT",
    "auditorlocation": "Brisbane, Australia"
  },
  {
    "date": "2022-06-30",
    "symbol": "IXHL",
    "period": "FY",
    "otherfinanceincomecost": 788654,
    "otheroperatingincomeexpense": 788654,
    "costofsales": 6338,
    "administrativeexpense": 280969,
    "advertisingexpense": 2746226,
    "expenserecognisedduringperiodforbadanddoubtfuldebtsforrelatedpartytransaction": 134626,
    "researchanddevelopmentexpense": 5371821,
    "brokeragefeeexpense": 3559511,
    "sharebasedcompensation": 1464550,
    "occupancyexpense": 112341,
    "employeebenefitsexpense": 2016181,
    "expensebynature": 15692563,
    "profitlossbeforetax": -14903909,
    "profitlossfromcontinuingoperations": -14903909,
    "comprehensiveincome": -14903909,
    "basicearningslosspershare": -1.25,
    "dilutedearningslosspershare": -1.25,
    "cashandcashequivalents": 37500931,
    "tradeandothercurrentreceivables": 294717,
    "othercurrentassets": 37559819,
    "currentassets": 37879608,
    "assets": 37559819,
    "tradeandothercurrentpayables": 2010533,
    "currentliabilities": 2010533,
    "liabilities": 1078404,
    "netassetsliabilities": 35869075,
    "issuedcapital": 86586794,
    "capitalreserve": 8077191,
    "retainedearnings": -58794910,
    "equity": -58794910,
    "stockissuedduringperiodvaluestockoptionexercised": 40274242,
    "shareplacements": 400000,
    "sharesissuedtoadvisors": 450000,
    "increasedecreasethroughsharebasedpaymenttransactions": 1464550,
    "increasedecreaseinnumberofordinarysharesissued": 1,
    "increasedecreaseinnumberofordinarysharesissuedcosts": -389555,
    "profitloss": -14903909,
    "othercashreceiptsfromoperatingactivities": 782383,
    "paymentstosuppliersforgoodsandservicesandtoandonbehalfofemployees": 13596027,
    "interestpaidclassifiedasoperatingactivities": 6271,
    "cashflowsfromusedinoperatingactivities": -12807373,
    "proceedsfromissuingshares": 41184687,
    "cashflowsfromusedinfinancingactivities": 41184687,
    "increasedecreaseincashandcashequivalents": 28377314,
    "cashandcashequivalentsclassifiedaspartofdisposalgroupheldforsale": 9123617,
    "parententitydisclosurestextblock": "21.Parent entity disclosures ",
    "descriptionofaccountingpolicyfornatureofoperationspolicytextblock": "Nature of Operations ",
    "descriptionofaccountingpolicyforneworamendedaccountingstandardsandinterpretationsadoptedpolicytextblock": "New or amended Accounting Standards and Interpretationsadopted ",
    "descriptionofaccountingpolicyforstatementofcompliancepolicytextblock": "Statement of compliance ",
    "descriptionofaccountingpolicyforprinciplesofconsolidationpolicytextblock": "Principles of consolidation ",
    "descriptionofaccountingpolicyforoperatingsegmentspolicytextblock": "Operating segments ",
    "descriptionofaccountingpolicyfordividendspolicytextblock": "Dividends ",
    "descriptionofaccountingpolicyfornewaccountingstandardsnotyetadoptedpolicytextblock": "New Accounting Standards not yet adopted ",
    "disclosureofrevenueexpensestextblock": "            Consolidated             2022      2021       (a) Revenue (point in time)     $      $     Cannabinoid oils sales      -       1,897,596              -       1,897,596       (b) Other income                      Income from other arrangements      -       35,569       Government grants      -       37,500       Interest      6,271       2,679       Refundable R&D tax offset      782,383       -              788,654       75,748   ",
    "scheduleoftradeandotherreceivablescurrenttabletextblock": "      Current     Consolidated             2022      2021              $       $       Other receivables      -       53,447       GST recoverable      294,717       115,641              294,717       169,088    ",
    "scheduleofotherassetscurrenttabletextblockl": "      Prepayments      45,911       29,784       Office rental bond      24,124       -       Prepayment clinical trial insurance      13,925       6,306              83,960       36,090   ",
    "scheduleoftradeandotherpayablescurrenttabletextblock": "      Trade payables      1,300,696       233,117       Accrued expenses      415,449       381,717       Employee leave entitlements      294,388       140,215              2,010,533       755,049   ",
    "disclosureofissuedofsharecapitaltabletextblock": "            Consolidated             2022      2021              $       $             86,586,794       45,852,107  ",
    "disclosureofreserveswithinequitytabletextblock": "      Equity based premium reserve     Consolidated             2022      2021             $      $       Balance at 1 July 2021      6,612,641       1,490,588       Options issued to advisors1      -       4,522,010       Equity instruments issued to management and directors      1,464,550       600,043       At 30 June 2022      8,077,191       6,612,641    ",
    "scheduleofnumberofperformancesharesandperformancerightstextblock": "      Security Description     $0.$0.08 Options      Balance at start of year      Granted by the Company      Converted or Expired      Balance at end of year       30 June 2022      30-Sep-21       -       -       -       -       30 June 2021      30-Sep-21       41,553,593       -       (41,553,593)      -     ",
    "otherrevenue": 782383,
    "revenuefrominterest": 6271,
    "refundablerdtaxoffset": 782383,
    "totalotherincome": 788654,
    "interestincomeondebtinstrumentsheld": 6271,
    "otherexpensebynature": 15692563,
    "deferredtaxliabilityasset": 37879608,
    "segmentliabilities": 2010533,
    "taxexpenseincomeatapplicabletaxrate": 3725977,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 564872,
    "nonassessableincome": 195596,
    "deferredtaxassets": 3356701,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 24845264,
    "taxbenefitarisingfrompreviouslyunrecognisedtaxlosstaxcreditortemporarydifferenceofpriorperiodusedtoreducedeferredtaxexpense": 6211316,
    "averageeffectivetaxrate": 0.25,
    "taxbenefitpercentage": 0.25,
    "basicearningslosspersharefromdiscontinuedoperations": -1.25,
    "weightedaveragenumberofordinarysharesnumberinshares": 1191154011,
    "cashonhand": 37500931,
    "cash": 37500931,
    "adjustmentsforsharebasedpayment": 1464550,
    "noncashexpenseforannualleave": -594394,
    "adjustmentsfordecreaseincreaseintradeandotherreceivable": -92320,
    "adjustmentsfordecreaseincreaseinothercurrentassets": 53447,
    "adjustmentsforincreasedecreaseintradeandotherpayable": 1111080,
    "adjustmentsforincreasedecreaseinothercurrentliabilities": 154173,
    "cashflowsfromusedinoperatingactivitiescontinuingoperations": -12807373,
    "gstrecoverable": 294717,
    "totaltradeandotherreceivablescurrent": 294717,
    "currentprepayments": 45911,
    "rentalexpense": 24124,
    "prepaymentclinicaltrialinsurance": 13925,
    "otherassets": 83960,
    "tradeandotherpayablestotradesuppliers": 1300696,
    "currentaccruedexpensesandothercurrentliabilities": 415449,
    "otheremployeeexpense": 294388,
    "total": 2010533,
    "issuedcapitalordinaryshares": 86586794,
    "depositsfromcustomers": 86586794,
    "numberofsharesissuedandfullypaid": 1292334028,
    "issuesofnewsharesplacements": 400000,
    "numberofsharesissued": 5000000,
    "numberofsharesauthorised": 10000000,
    "proceedsfromexerciseofoptions": 40274243,
    "exerciseofoptions": 207650638,
    "sharesinlieuofadvisorfeesinshares": 450000,
    "numberofsharessharesinlieuofadvisorfees": 1272166,
    "paymentsforshareissuecosts": 389555,
    "otherreserves": 8077191,
    "profitlossattributabletoordinaryequityholdersofparententityincludingdilutiveeffects": 1464550,
    "numberofoptionsgrantedtodirectors": 1400002,
    "shareoptionsgrantedtodirectorsgrantdate": "09-Jun-22",
    "expirydateofoptionsgrantedtodirectors": "01-Jul-28",
    "exercisepriceofoptionsgrantedtodirectors": 0.35,
    "totalfairvalueofoptionsgrantedtodirectors": 347200,
    "numberoptionsgrantedtoemployees": 533334,
    "shareoptionsgrantedtoemployeesgrantdate": "29-Apr-22",
    "expirydateoptionsgrantedtoemployees": "01-Jul-27",
    "exercisepricetotaloptionsgrantedtoemployees": 0.35,
    "totalfairvalueoptionsgrantedtoemployees": 148800,
    "shareoptions": 10000000,
    "totaloptions": 2371867,
    "exercisepriceofoutstandingshareoptions2019": 0.08,
    "weightedaverageshares": 533334,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.8,
    "riskfreeinterestrate": 0.028999999999999998,
    "expectedlifeofoption": 5.18,
    "exercisepriceshareoptionsgranted2019": 35,
    "grantdatepricepershare": 41,
    "vestingdateperiod": "01-Jul-24",
    "options": "30-Sep-21",
    "auditorsremunerationfortaxservices": 85000,
    "auditorsremunerationforauditservices": 23138,
    "auditserviceswithumsmithbrownusauditor": 357208,
    "auditorsremuneration": 465346,
    "tradeandotherpayables": 1828527,
    "otherpayables": 1828527,
    "shorttermemployeebenefitsexpense": 1333992,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 47547,
    "provisionsforemployeebenefits": 1028634,
    "keymanagementpersonnelcompensationsharebasedpayment": 2410173,
    "othercurrentliabilities": 1078404,
    "financialassets": 36481415,
    "surplusdeficitinplan": -58182570,
    "equityandliabilities": 36481415,
    "impairmentlossrecognisedinothercomprehensiveincome": 14900000,
    "netcashoutflowsfromoperations": 12800000,
    "heldtotalcash": 37500000,
    "finitelivedintangibleassetusefullifes": 10,
    "numberofoperatingsegment": 3,
    "numberofgeographicalsegment": 1,
    "percentageoftotalrevenuefrommedicinalcannabis": 1,
    "commonstockvotingright": "one",
    "fairvalue": 3588000,
    "unrecognizedcompensationcost": 1853263,
    "weightedaverageperiodterm": 1.39,
    "performancerightsconvertedintoordinaryshare": 30303593,
    "performancerightsexpired": 11250000,
    "percentageofentitysrevenue": 0.5,
    "feeandcommissionincome": 407824,
    "proportionofownershipinterestinsubsidiary": 1,
    "entityregistrantname": "Incannex Healthcare Limited",
    "tradingsymbol": "IXHL",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "June 30",
    "entitycommonstocksharesoutstanding": 1292334028,
    "amendmentflag": "false",
    "entitycentralindexkey": 1873875,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "June 30, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-41106",
    "entityincorporationstatecountrycode": "Australia",
    "entityaddressaddressline1": "Suite 105",
    "entityaddressaddressline2": "8 Century Circuit",
    "entityaddresspostalzipcode": 2153,
    "entityaddresscityortown": "NSW",
    "entityaddresscountry": "Australia",
    "contactpersonnelname": "Joel Latham",
    "cityareacode": 61,
    "localphonenumber": "425 703 805",
    "contactpersonnelemailaddress": "joel@incannex.com.au",
    "security12btitle": "Ordinary Shares, as represented by American Depositary Shares",
    "securityexchangename": "The Nasdaq Stock Market LLC",
    "securityreportingobligation": "15(d)",
    "entityinteractivedatacurrent": "Yes",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "auditorfirmid": 6622,
    "auditorname": "WithumSmith+Brown, PC",
    "auditorlocation": "New York, New York"
  }
]